Labo Euromedis (XPAR:ALEMG) EV-to-FCF : -0.71 (As of Jun. 12, 2024)

Labo Euromedis EV-to-FCF Chart

Labo Euromedis Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-FCF		Get a 7-Day Free Trial					-12.11	3.35	0.88	-0.13	-

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-FCF	Get a 7-Day Free Trial															0.88	-	-0.13	-	-

Competitive Comparison of Labo Euromedis's EV-to-FCF

For the Medical Devices subindustry, Labo Euromedis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's EV-to-FCF falls into.

Labo Euromedis EV-to-FCF Calculation

Labo Euromedis's EV-to-FCF for today is calculated as:

Labo Euromedis's current Enterprise Value is €3.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was €-5.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis  (XPAR:ALEMG) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Labo Euromedis's PE Ratio for today is calculated as:

Labo Euromedis's share price for today is €4.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €4.651.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Labo Euromedis EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (XPAR:ALEMG) Business Description